AI assistant
CONMED Corp — Director's Dealing 2025
May 15, 2025
31971_dirs_2025-05-15_c864ff43-12ed-4edd-ac0e-48e0cbfd7ebc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2025-02-24
Reporting Person: Epinette Stephan (VP GM International)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 15510 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options To Purchase Common Stock | $96.16 | 2033-03-01 | Common Stock (7500) | Direct | |
| Options To Purchase Common Stock | $79.95 | 2034-03-01 | Common Stock (7500) | Direct | |
| RSUs (Restricted Stock Units) | $0 | 2032-03-01 | Common Stock (1375) | Direct | |
| RSUs (Restricted Stock Units) | $0 | 2033-03-01 | Common Stock (3000) | Direct | |
| RSUs (Restricted Stock Units) | $0 | 2034-03-01 | Common Stock (4500) | Direct |
Footnotes
F1: Stephan Epinette became an officer of CONMED Corporation on February 24, 2025. Exhibit index Power of Attorney (public).
F2: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
F3: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.